Share ideas that matter on the social web and experience
the benefits of curating the world's best content.
I don't have a Facebook, a Twitter or a LinkedIn account
|
Scooped by Peter Verschuere onto The Jazz of Innovation |
Scoop.it!
Genomic sequencing might be more common in medicine if doctors had a simple way to send for the test and keep track of the data.
That’s the hope of Coriell Life Sciences in Camden, New Jersey, a startup that grew out of a partnership between the Coriell Institute for Medical Research and IBM. The company wants to facilitate the process of ordering, storing, and interpreting whole-genome-sequence data for doctors.
Are you sure you want to delete this scoop?
 Your new post is loading...
Scoop.it!
In 2009, 12 people participated in a clinical trial through which they received an experimental gene therapy for an inherited form of blindness. The correct form of the gene, meant to replace their faulty ones, was injected into the retinal cells of one eye. Limiting the injection to one eye was precautionary, since the researchers didn’t know if there would be any adverse affects. Delete the scoop?
Are you sure you want to delete this scoop?
Yes
|
